MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status

W. D. Foulkes, G. W.H. Stamp, S. Afzal, N. Lalani, C. P. McFarlane, J. Trowsdale, I. G. Campbell

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)

Fingerprint

Dive into the research topics of 'MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status'. Together they form a unique fingerprint.

Medicine and Dentistry